Cargando…

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole

BACKGROUND: Skeletal involvement of Cryptococcus neoformans is infrequent and usually associated with disseminated cryptococcosis or underlying predisposing conditions. We present an atypical case of osteoarticular cryptococcosis in an immunocompetent patient. CASE PRESENTATION: We herein report a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deus, Guillem, Gómez-Zorrilla, Silvia, Echeverria-Esnal, Daniel, Siverio, Ana, Güerri-Fernandez, Robert, Ares, Jesús, Campillo, Nuria, Letang, Emili, Knobel, Hernando, Grau, Santiago, Horcajada, Juan Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917311/ https://www.ncbi.nlm.nih.gov/pubmed/33658808 http://dx.doi.org/10.2147/IDR.S294299

Ejemplares similares

High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis
por: Santos, Julliana Ribeiro Alves, et al.
Publicado: (2017)

Mutants with heteroresistance to amphotericin B and fluconazole in Candida
por: Claudino, A.L.R., et al.
Publicado: (2009)

Application of caspofungin in China compared with amphotericin B and fluconazole
por: Zhang, Chunyu, et al.
Publicado: (2014)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2021)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2022)

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
por: Dromer, Françoise, et al.
Publicado: (2008)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by Escherichia coli or Klebsiella pneumoniae: The Role of Prior Exposure to Fluoroquinolones
por: Martínez-Casanova, Javier, et al.
Publicado: (2021)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine
por: Storm, Line, et al.
Publicado: (2014)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis
por: Santos, Julliana Ribeiro Alves, et al.
Publicado: (2014)

Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
por: Fay, Vanessa da Silva, et al.
Publicado: (2018)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Antimicrobial Consumption among 66 Acute Care Hospitals in Catalonia: Impact of the COVID-19 Pandemic
por: Grau, Santiago, et al.
Publicado: (2021)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates
por: de Aquino Lemos, Janine, et al.
Publicado: (2009)

Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?
por: Montero, María Milagro, et al.
Publicado: (2020)

Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study
por: López Montesinos, Inmaculada, et al.
Publicado: (2021)

P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans
por: Aslani, Narges
Publicado: (2022)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

A retrospective case-control study to evaluate the use of beta-lactam desensitization in the management of penicillin-allergic patients: a potential strategy for Antimicrobial Stewardship Programs
por: Rodríguez-Alarcón, Alicia, et al.
Publicado: (2023)

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan
por: Yang, Yun-Liang, et al.
Publicado: (2005)

An Elderly Patient with Pulmonary Cryptococcosis with Mediastinal Lymphadenopathy Who Was Successfully Treated with Amphotericin B and Flucytosine
por: Fujimoto, Shusaku, et al.
Publicado: (2020)

Antifungal Properties of Nerolidol-Containing Liposomes in Association with Fluconazole
por: Fonseca Bezerra, Camila, et al.
Publicado: (2020)

Invasive Cryptococcosis and Adalimumab Treatment
por: Horcajada, Juan P., et al.
Publicado: (2007)

Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections
por: Schiave, Letícia Aparecida, et al.
Publicado: (2017)

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2019)

Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Suchodolski, Jakub, et al.
Publicado: (2021)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2021)

Combined effect of furanone fluconazole and amphotericin B against biofilms formed from Cryptococcus neoformans
por: Meenakumari, Kirishnamoorthy, et al.
Publicado: (2021)

The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms
por: Tóth, Zoltán, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_70eaf1qtn9r7mofk5er4j53mf4